Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China
· Delayed Price · Currency is CNY 96.00
-3.69 (-3.70%)
At close: Apr 29, 2026
SHA:688198 Revenue
Beijing Balance Medical Technology had revenue of 143.56M CNY in the quarter ending March 31, 2026, with 43.36% growth. This brings the company's revenue in the last twelve months to 663.57M, up 26.21% year-over-year. In the year 2025, Beijing Balance Medical Technology had annual revenue of 620.15M with 23.57% growth.
Revenue (ttm)
663.57M
Revenue Growth
+26.21%
P/S Ratio
20.69
Revenue / Employee
1.09M
Employees
670
Market Cap
13.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 620.15M | 118.27M | 23.57% |
| Dec 31, 2024 | 501.88M | 131.24M | 35.41% |
| Dec 31, 2023 | 370.64M | 75.47M | 25.57% |
| Dec 31, 2022 | 295.17M | 43.35M | 17.21% |
| Dec 31, 2021 | 251.82M | 69.90M | 38.42% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jafron Biomedical | 2.04B |
| MeHow Innovative | 1.73B |
| Shandong Weigao Blood Purification Products | 3.77B |
| Shandong Weigao Orthopaedic Device | 1.52B |
| Shanghai MicroPort Endovascular MedTech | 1.35B |
| SonoScape Medical | 2.31B |
| Double Medical Technology | 2.60B |
| Cofoe Medical Technology | 3.39B |